rubschisandrin has been researched along with homoorientin in 1 studies
| Studies (rubschisandrin) | Trials (rubschisandrin) | Recent Studies (post-2010) (rubschisandrin) | Studies (homoorientin) | Trials (homoorientin) | Recent Studies (post-2010) (homoorientin) |
|---|---|---|---|---|---|
| 5 | 0 | 2 | 136 | 1 | 96 |
| Protein | Taxonomy | rubschisandrin (IC50) | homoorientin (IC50) |
|---|---|---|---|
| rac GTPase-activating protein 1 isoform a | Homo sapiens (human) | 40.92 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, G; Wang, J; Wang, Y; Wei, J; Yang, J; Zhang, J | 1 |
1 review(s) available for rubschisandrin and homoorientin
| Article | Year |
|---|---|
Development of inhibitors targeting glycogen synthase kinase-3β for human diseases: Strategies to improve selectivity.
Topics: Glycogen Synthase Kinase 3 beta; Humans; Neoplasms | 2022 |